Erlanger
Giuseppe Pizzorno has a diverse work experience in the field of medical research and academia. Giuseppe is currently serving as the Regional Medical Director for the Clinical Trials Network of Tennessee (CTN2) at the University of Tennessee College of Medicine Chattanooga, as well as the Chair of the Clinical Trials Governance Board (CTGB) at The University of Tennessee Health Science Center. Giuseppe has been an Executive Committee Member of the Clinical Trials Network of Tennessee (CTN2) Board since 2019. Prior to these roles, they held positions such as Professor and Associate Dean for Research at the University of Tennessee-Health Science Center College of Medicine, Chief Research Officer at Erlanger Health System, and Principal Owner of Pizzorno Scientific Consulting. Giuseppe also worked as a Research Professor and Program Director at the Desert Research Institute and served as the Co-Founder and Deputy Director/Vice President of Research Operations at the Nevada Cancer Institute. Earlier in their career, they held various positions at Yale University School of Medicine, including Associate Professor, Research Director of Yale Pediatric Pharmacology Research Unit, Director Clinical Pharmacology at Yale Cancer Center, and Assistant Professor.
Giuseppe Pizzorno completed their education with a Doctorate in Pharmaceutical Chemistry and Technology from Università degli Studi di Genova, from 1977 to 1983. Giuseppe then pursued a Doctor of Pharmacy (Pharm.D.) degree at the same institution from 1978 to 1984. Afterwards, they undertook a Postdoctoral Fellowship in Pharmacology/Oncology at Yale University School of Medicine from 1986 to 1988.
Erlanger
2 followers
Erlanger, named among "America's Best Hospitals" by U.S. News & World Report, is a non-profit, academic teaching center affiliated with the University of Tennessee College of Medicine. Erlanger is also a Level-One Trauma Center for adults and the only provider of tertiary care services for the citizens of an entire four-state region, encompassing southeast Tennessee, north Georgia, north Alabama and western North Carolina. With a history that dates back more than a century, Erlanger is recognized as one of the nation's finest public hospitals and a leader in healthcare. The Erlanger Health System includes Children's Hospital at Erlanger (CHE), the only academic medical center in the tri-state region devoted solely to children and is a Comprehensive Regional Pediatric Center (CRPC)— the highest designation in the state for pediatrics. CHE has a full range of pediatric subspecialists, as well as a pediatrics ER, ICU, and Level III neonatal intensive care unit, providing the highest level of care in the region for premature and sick infants. Each year, more than a quarter of a million people are treated by the team of healthcare professionals who are part of Erlanger.